If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Baqsimi™ (glucagon) nasal powder
3mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
BAQSIMI™ (glucagon) nasal powder: Oral Administration and Ingestion
Oral administration and ingestion of Baqsimi (glucagon nasal powder) has not been studied in people with diabetes.
Oral administration and ingestion of Baqsimi has not been studied in people with diabetes. As such, we have no information on the oral or buccal absorption of Baqsimi.
Glucagon is a single-chain polypeptide.1,2
Glucagon for injection is not active when administered and ingested orally because it is a polypeptide that is destroyed in the gastrointestinal tract before it can be absorbed.2
Enclosed Prescribing Information
BAQSIMI™ (glucagon) nasal powder, for intranasal use, Lilly
1. Baqsimi [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.
2. Glucagon for Injection [package insert]. Indianapolis, IN: Eli Lilly and Company; 2018.
Glossary
Baqsimi = Baqsimi™ (glucagon) nasal powder
Date of Last Review: August 23, 2019
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 8pm ET
